Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...